Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK Alli Strategy Relies Even More On Users Spreading The Word

This article was originally published in The Tan Sheet

Executive Summary

Heading into its second year selling weight-loss drug alli over the counter, GlaxoSmithKline wants users to do the talking
Advertisement

Related Content

Sanofi Needs Switch Skills To Span Gap Between Rx And OTC Divisions
Sanofi Needs Switch Skills To Span Gap Between Rx And OTC Divisions
Sanofi Needs Switch Skills To Span Gap Between Rx And OTC Divisions
GSK’s Alli Marketing Plays Celebrity Endorsement Tune
GSK’s Alli Marketing Plays Celebrity Endorsement Tune
GSK’s Alli Marketing Plays Celebrity Endorsement Tune
Behavioral Science Banner Maps The Future Of GSK Consumer Business
GSK Consumer Sales Remain Strong As Rx Revenue Slips
Alli Approved OTC For Weight Loss With “Goal Oriented” Indication
Alli Approved OTC For Weight Loss With “Goal Oriented” Indication

Topics

Advertisement
UsernamePublicRestriction

Register

PS101849

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel